OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

2 Projects | 1 Researchers | $223,000 Invested

2012

University of British Columbia Hospital

Cheryl Wellington, PhD

Novel modulators of apoE function

  • Funding Amount: $148,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2008

University of British Columbia Hospital

Cheryl Wellington, PhD

The therapeutic potential of ABCA1 and apoE for Alzheimer's Disease

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed